首页
> 会议日程详情
四川省肿瘤医院
2024-11-15
2
2024-11-16
1
论文交流-35
[论文发言]
13:20-13:28 
719阿里山 
Transarterial chemoembolisation and tyrosine kinase inhibitors with or without programmed death-1 inhibitors as first-line treatment for unresectable hepatocellular carcinoma: A propensity score matching study 查看详情>>